# Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients

> **NCT06934811** · PHASE4 · NOT_YET_RECRUITING · sponsor: **First Affiliated Hospital of Wannan Medical College** · enrollment: 30 (estimated)

## Conditions studied

- ECMO Treatment
- ARDS (Acute Respiratory Distress Syndrome)
- ECMO and Acute MI
- Respiratory Failure Patients Treated With ECMO
- Shock, Cardiogenic

## Interventions

- **DRUG:** Ciprofol
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT06934811
- **Lead sponsor:** First Affiliated Hospital of Wannan Medical College
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06934811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06934811, "Ciprofol's Impact on Oxygenator Function in Extracorporeal Membrane Oxygenation (ECMO) Patients". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06934811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*